Drexel Morgan & Co. Merck & Co., Inc. Transaction History

Drexel Morgan & Co.

$538 Million
Q3 2024

A detailed history of Drexel Morgan & Co. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Drexel Morgan & Co. holds 29,292 shares of MRK stock, worth $3.02 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

29,292

Previous 29,292 -0.0%

Holding current value

$3.02 Million

Previous $3.63 Million 8.27%

% of portfolio

0.62%

Previous 0.78%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$123.8 - $132.96 $51,129 - $54,912	413 Added 1.43%	29,292 $3.63 Million
Q4 2023 Feb 08, 2024	BUY	$100.18 - $109.02 $228,510 - $248,674	2,281 Added 8.58%	28,879 $3.15 Million
Q3 2023 Nov 08, 2023	BUY	$102.95 - $114.33 $48,901 - $54,306	475 Added 1.82%	26,598 $2.74 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $42,265 - $47,480	500 Added 1.95%	26,123 $2.25 Million
Q2 2022 Aug 12, 2022	BUY	$83.49 - $94.64 $54,268 - $61,516	650 Added 2.6%	25,623 $2.34 Million
Q1 2022 May 02, 2022	BUY	$73.51 - $82.4 $276,985 - $310,483	3,768 Added 17.77%	24,973 $2.05 Million
Q3 2021 Nov 12, 2021	SELL	$71.68 - $78.83 $99,348 - $109,258	-1,386 Reduced 6.14%	21,205 $1.59 Million
Q2 2021 Aug 12, 2021	SELL	$70.31 - $77.77 $84,793 - $93,790	-1,206 Reduced 5.07%	22,591 $1.76 Million
Q1 2021 May 13, 2021	SELL	$68.86 - $81.11 $482 - $567	-7 Reduced 0.03%	23,797 $1.84 Million
Q3 2020 Nov 16, 2020	BUY	$73.18 - $82.95 $292 - $331	4 Added 0.02%	23,804 $1.98 Million
Q2 2020 Aug 11, 2020	BUY	$70.42 - $80.13 $6,549 - $7,452	93 Added 0.39%	23,800 $1.84 Million
Q1 2020 May 08, 2020	BUY	$63.36 - $87.82 $76,032 - $105,383	1,200 Added 5.33%	23,707 $1.82 Million
Q4 2019 Feb 10, 2020	SELL	$77.58 - $87.54 $180,683 - $203,880	-2,329 Reduced 9.38%	22,507 $2.05 Million
Q3 2019 Nov 13, 2019	BUY	$76.08 - $82.93 $456 - $497	6 Added 0.02%	24,836 $2.09 Million
Q2 2019 Aug 08, 2019	SELL	$69.84 - $81.59 $40,996 - $47,893	-587 Reduced 2.31%	24,830 $2.08 Million
Q1 2019 May 14, 2019	BUY	$69.58 - $79.36 $45,644 - $52,060	656 Added 2.65%	25,417 $2.11 Million
Q4 2018 Feb 14, 2019	BUY	$65.24 - $75.71 $110,842 - $128,631	1,699 Added 7.37%	24,761 $1.89 Million
Q3 2018 Nov 09, 2018	BUY	$57.69 - $67.84 $5,538 - $6,512	96 Added 0.42%	23,062 $1.64 Million
Q2 2018 Aug 09, 2018	BUY	$50.83 - $59.72 $93,527 - $109,884	1,840 Added 8.71%	22,966 $1.39 Million
Q1 2018 May 10, 2018	SELL	$50.96 - $59.23 $306,320 - $356,031	-6,011 Reduced 22.15%	21,126 $1.15 Million
Q4 2017 Feb 12, 2018	BUY	$51.62 - $61.64 $349,209 - $416,994	6,765 Added 33.21%	27,137 $1.53 Million
Q3 2017 Nov 13, 2017	SELL	$58.67 - $63.13 $27,633 - $29,734	-471 Reduced 2.26%	20,372 $1.31 Million
Q2 2017 Aug 14, 2017	BUY	N/A	20,843	20,843 $1.34 Million

Others Institutions Holding MRK

# of Institutions

3,824

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Drexel Morgan & Co., based on Form 13F filings with the SEC.

News

Stay updated on Drexel Morgan & Co. with notifications on news.

Account